| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |